CHRS NASDAQ
Coherus Oncology, Inc.
1W: +2.6%
1M: -18.3%
3M: -25.6%
YTD: -15.3%
1Y: -28.4%
3Y: -70.8%
5Y: -93.5%
$1.16
+0.00 (+0.00%)
Weekly Expected Move ±10.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$51M
Revenue
-64.3% YoY
$-131M
Net Income
-173.1% YoY
$-244M
Free Cash Flow
-130.4% YoY
70.4%
Gross Margin
-226.0%
Op. Margin
-144.2%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-145.4%
ROA-41.7%
ROIC1854.0%
Valuation
P/E-1.1
P/B3.0
EV/EBITDA-1.0
Leverage
Debt/Equity0.62
Current Ratio1.77
Interest Cov.-16.7x
Quality Scores
Piotroski F2/9
Altman Z-11.55
Beneish M-0.08